{"id":"W2104748005","doi":"10.1200/jco.2009.24.3030","title":"Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non–Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial","year":2009,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gefitinib; Docetaxel; Medicine; Lung cancer; Oncology; Internal medicine; Biomarker; Hazard ratio; Epidermal growth factor receptor; KRAS; Cancer; Confidence interval; Biology; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004019459,0.0007160379,0.001627632,0.0002321809,0.0002563594,0.0008311191,0.0005756865,0.0008288082,0.001326755],"category_scores_gemma":[0.003399608,0.0002294454,0.001796056,0.000321167,0.0007003933,0.0006458308,0.000267391,0.001317369,0.0002194961],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007452452,"about_ca_system_score_gemma":0.0007119651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007406171,"about_ca_topic_score_gemma":0.001748868,"domain_scores_codex":[0.9983943,0.001103005,0.00009919783,0.0001743635,0.0001203095,0.0001088767],"domain_scores_gemma":[0.9969087,0.001072034,0.001051449,0.0002342933,0.0001224963,0.0006109776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9272063,0.002693864,0.04129811,0.0003089435,0.00270658,0.00005858679,0.0000470347,0.001347392,0.001955108,0.0001163588,0.0011913,0.02107045],"study_design_scores_gemma":[0.602308,0.1483404,0.2334052,0.0001199087,0.00603695,0.0003012393,0.00009538574,0.003998077,0.002008289,0.0005108843,0.002799426,0.00007629891],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949666,0.003199431,0.0001729848,0.0002640204,0.00007525808,0.0001899449,0.0006321578,0.00001852262,0.0004810616],"genre_scores_gemma":[0.9962814,0.0008788065,0.0002725756,0.000261405,0.0001443414,0.0002683543,0.001513734,0.000008293525,0.000370996],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004019459,"threshold_uncertainty_score":0.02125716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1212243943653459,"score_gpt":0.490069456183446,"score_spread":0.3688450618181001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}